Qing-Cheng Yang (Qingcheng Yang)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

End Stage Renal Disease

Signaling Pathway

Immune Response

Top Venues

Cell death & disease

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Zhou, Qing-Cheng Yang, Yang Dong, Tong Ji, Bing Zhang, Cheng Yang, Shuier Zheng, Lina Tang, Chenliang Zhou, Guowei Qian, Yujing Huang, Wenxi Yu, Hongtao Li, Yonggang Wang, Aina He, Zan Shen, Weibin Zhang, Yingqi Hua, Hongyu Bai, Jiayi Zhao, Benjamin X Li, Xiangrong Dai, Jianjun Zhang, Hai-Yan Hu, Yang Yao
First-in-maintenance therapy for localized high-grade osteosarcoma: an open-label phase I/II trial of the anti-PD-L1 antibody ZKAB001. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Zhen Pan, Xiao-Juan Wei, Shi-Jie Li, Hua Guo, Zhao-Hui Li, Ke-Ke Zhang, Qian-Qian Lyu, Wei-Zhi Liu, Qing-Cheng Yang, Dong-Dong Cheng
Sulfated alginate oligosaccharide exerts antitumor activity and autophagy induction by inactivating MEK1/ERK/mTOR signaling in a KSR1-dependent manner in osteosarcoma. Oncogenesis 11 (1) (2022)
Shanyi Lin, Lenian Zhou, Yang Dong, Qing-Cheng Yang, Quanjun Yang, Hanqiang Jin, Ting Yuan, Shumin Zhou
Alpha-(1,6)-fucosyltransferase (FUT8) affects the survival strategy of osteosarcoma by remodeling TNF/NF-κB2 signaling. Cell death & disease 12 (12) (2021)
Yunfei He, Dongdong Cheng, Cheng Lian, Yingjie Liu, Wenqian Luo, Yuan Wang, Chengxin Ma, Qiuyao Wu, Pu Tian, Dasa He, Zhenchang Jia, Xianzhe Lv, Xue Zhang, Zhen Pan, Jinxi Lu, Yansen Xiao, Peiyuan Zhang, Yajun Liang, Qing-Cheng Yang, Guo-Hong Hu
Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone. Cell death & disease 12 (10) (2021)